DCGI approves anti-Covid drug made by DRDO
The Drugs Controller General of India (DCGI) has approved drug 2-deoxy-D-glucose (2-DG) for emergency use as an adjunct therapy in moderate to severe Covid-19 cases.
According to reports, the drug has been developed by DRDO Lab Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories. Clinical trials have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
In a tweet written by PIB India it read, “Drugs Controller General of India approves anti-COVID drug developed by @DRDO_India for emergency use. Clinical trial results have shown that this molecule helps in faster recovery of hospitalized patients and reduces supplemental oxygen dependence.”
India on Friday reported over 4.01 lakh new coronavirus infections with over 4,000 new deaths.
92267 828701I recognize there is definitely a fantastic deal of spam on this weblog. Do you want aid cleansing them up? I could support in between classes! 99214
494475 489800Excellent weblog, Im going to spend a lot more time reading about this topic 925796
387478 516698This web page is often a walk-through its the internet you wanted about this and didnt know who to question. Glimpse here, and youll absolutely discover it. 159421
969434 13344Youre so cool! I dont suppose Ive read anything like this before. So nice to search out any individual with some original thoughts on this subject. realy thank you for starting this up. this web site is 1 thing thats wanted on the web, somebody with a bit of originality. valuable job for bringing something new to the internet! 220038
74791 513551Thanks for some other fantastic post. Where else may just anyone get that type of info in such an ideal means of writing? Ive a presentation next week, and Im at the search for such info. 312540
Explore the ranked best online casinos of 2025. Compare bonuses, game selections, and trustworthiness of top platforms for secure and rewarding gameplaycasino bonus.